These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8513598)

  • 1. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
    Mitsuhashi H; Tsukada Y; Ono K; Yano S; Naruse T
    Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
    Tencer J; Torffvit O; Björnsson S; Thysell H; Grubb A; Rippe B
    Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
    Taira K; Hewitson TD; Kincaid-Smith P
    Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary glycosaminoglycan composition in chronic glomerulonephritis.
    De Muro P; Faedda R; Satta A; Finetti D; Masala A; Cigni A; Sanna GM; Cherchi GM
    J Nephrol; 2005; 18(2):154-60. PubMed ID: 15931643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary excretion of glycosaminoglycans and heparan sulphate in lupus nephritis.
    Parildar Z; Uslu R; Tanyalcin T; Doganavsargil E; Kutay F
    Clin Rheumatol; 2002 Aug; 21(4):284-8. PubMed ID: 12189454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced urinary excretion of intact osteopontin in patients with IgA nephropathy.
    Gang X; Ueki K; Kon S; Maeda M; Naruse T; Nojima Y
    Am J Kidney Dis; 2001 Feb; 37(2):374-9. PubMed ID: 11157380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of glomerular heparan sulfate domains in pediatric patients with minimal change nephrotic syndrome].
    Dong LQ; Wang Z; Yu P; Guo YN; Wu J; Feng SP; Li S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):55-8. PubMed ID: 19292045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K; Kanmatsuse K
    Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine glycosaminoglycans in congenital and acquired nephrotic syndrome.
    Jadresic LP; Filler G; Barratt TM
    Kidney Int; 1991 Aug; 40(2):280-4. PubMed ID: 1942776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
    Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
    Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.
    Kobayashi S; Amano H; Terawaki H; Ogura M; Kawaguchi Y; Yokoo T
    BMC Nephrol; 2019 Aug; 20(1):306. PubMed ID: 31387546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
    Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
    J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the modified dimethylmethylene-blue (DMB) method for determining glycosaminoglycans (GAG) in urine].
    Moriyama M; Suzuki K; Nakajima C; Kawamura K; Miyazawa K; Tsugawa R
    Hinyokika Kiyo; 1994 Jul; 40(7):565-8. PubMed ID: 8085515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
    Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
    Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
    J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on albumin metabolism in nephrotic syndrome].
    Komatsu Y
    Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1243-51. PubMed ID: 2082057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity.
    De Muro P; Faedda R; Satta AE; Masala A; Cigni A; Falconi D; Sanna GM; Cherchi GM
    Scand J Urol Nephrol; 2007; 41(3):230-6. PubMed ID: 17469033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome.
    Vermylen C; Levin M; Mossman J; Barratt TM
    Pediatr Nephrol; 1989 Apr; 3(2):122-9. PubMed ID: 2534970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.